H.I.G. BioHealth Partners is the life-science investment affiliate of H.I.G. Capital, focusing on growth, venture, and special situations investments across various life science sectors and stages. The firm primarily invests in companies developing therapeutic drugs, medical devices, and diagnostics that address significant unmet medical needs, aiming to improve patient outcomes and reduce healthcare costs.
100% of their portfolio is in Biotech & Life Sciences.
Portfolio
2
Fund Size
$400M
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 On Target Laboratories, Inc. | Series B | $44M | Mar 2018 |
 Arvelle Therapeutics | Unknown | — | — |
Top Co-Investors
NovaQuest Capital Management1 shared
LSP1 shared
BRV Capital1 shared
Andera Partners1 shared
Elevate Ventures1 shared
Last updated: 28 April 2026